Don Weissman, MD

Life Sciences and Healthcare


Medical & Regulatory Affairs
Strategic Business Development
 Marketing and Communications
 
KOL Relationships, Identification, Governance

Senior Medical Science Liaison

 

   Initiatives, Alliances, Partnerships 
  Clinical and Commercial Optimization 


 

 

"A MISSION OF BETTER HEALTH, LONGEVITY and QUALITY OF LIFE

 

Strategic Business and Market Development

Medical Science Liaison  

Medical and Regulatory Affairs 

   KOL Relationships and Governance

  

   Biotech-Pharmaceuticals, Devices, Technologies,

Diagnostics, AI, Genetics, Trials and Services.


Excellent KOL, HCP and C level relationships, 

 communications and development 

Life Sciences and Healthcare, 

Academic, Corporate and Clinical 


Proven track record of success helping Life Science Companies 

and Healthcare Institutions accelerate commercial development,

optimize market share and success for patient benefits,

better outcomes and quality of life, 

caretaker, provider and stakeholder values. 

 

Exceptional education, success and experience,

 presentations, communications and interpersonal skills.


Key Opinion Leader insights, 

 scientific exchange and rapport. 

Trials, data analytics, compliance,

 applications, adoption and advocacy.


Advisory Board Development, Honored Society

 and Board Relationships with Subject Matter Experts,

 Academic & University Medical Centers, 

Physicians of Influence and Healthcare Decision Makers.

 

Analyst, Grant review and panel member for the

 National Science Foundation, the NSF. 
National Institute of Health, the NIH and 

Department of Health & Human Services, the HHS.

 Biotech & medical research, diagnostics, genomics

bio-pharmaceuticals, devices and therapeutics.


Adept listener, articulate and persuasive, 
building professional consensus for 
trials, applications, approvals, advocacy and coverage,
greater compliance and adherence, understanding
the needs, drivers and implementations for success. 
 
In-depth Medical and Regulatory affairs, 
pharmaco-economics, HEOR and vigilance for resource
allocation and guidelines. Highly successful with the FDA, FTC,
PhRMA, AHRQ and CMS. Proven track record of success for coverage
and reimbursements by government, insurance, payers and plans.
 

Honored society, academic and board relationships for strategic CME,
regional and national symposium, publications, brand
and market development, mobile and social media
applications with validation. 

 

Extraordinary resources, knowledge and success

developing and strengthening internal and external 

partnerships and alliances with renowned KOL's, academic, 

 corporate, government and clinical leaders.

 


GOALS:

 

                

Innovative therapeutics, diagnostics and services

to treat, ameliorate, cure and prevent.


 

To optimize patient well being, quality of life and 

Stakeholder values


 Excellence
in clinical, operational and financial outcomes.